Anjali Singh &Amp;Amp; Sanket Koul

Stories by Anjali Singh &Amp;Amp; Sanket Koul

Panel Flags CBSE's Dual Exam Plan

Panel Flags CBSE's Dual Exam Plan

Rediff.com   29 Mar 2025

In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026.

Latest trend in India's key realty markets

Latest trend in India's key realty markets

Rediff.com   18 Mar 2025

Capital value appreciation outpaced rental value growth in several key micro-markets between 2021 and 2024, with Noida Sector 150 in the National Capital Region (NCR) leading the pack with a 128 per cent rise in capital values compared to rental value growth of just 66 per cent, according to a report by property consulting firm Anarock.

Surge in e2W Launches Sparks Fierce Price Battle

Surge in e2W Launches Sparks Fierce Price Battle

Rediff.com   17 Mar 2025

From premium electric motorcycles to mass-market scooters, manufacturers are rapidly expanding their portfolios to capture a larger share of the booming market.

Why India's medical device makers are moving to Vietnam, Malaysia

Why India's medical device makers are moving to Vietnam, Malaysia

Rediff.com   14 Mar 2025

A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.

After Delhi's sign-in, Bengal only state to hold out on Ayushman Bharat

After Delhi's sign-in, Bengal only state to hold out on Ayushman Bharat

Rediff.com   28 Feb 2025

According to a parliamentary response by the Union health ministry in 2023, around 654,000 families in Delhi are eligible to enrol under the scheme.

Private hospitals to boost cancer care, beds count

Private hospitals to boost cancer care, beds count

Rediff.com   27 Feb 2025

'Cancer incidence is projected to increase by 12.8 per cent by 2025 compared with 2020, necessitating more dedicated cancer treatment centres and specialised beds.'

Audi shrugs off last year, plans to step on the gas

Audi shrugs off last year, plans to step on the gas

Rediff.com   21 Feb 2025

Audi plans to focus the Indian market, including deepening market penetration and increasing sales volume.

'7,000 More MBBS Seats, 3,000 For PG'

'7,000 More MBBS Seats, 3,000 For PG'

Rediff.com   17 Feb 2025

India is trying to add 75,000 medical seats in five years as it also eyes to touch the WHO standard of one doctor for every 1,000 persons.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

Auto revenue may hit high gear on rural push, launches

Auto revenue may hit high gear on rural push, launches

Rediff.com   28 Jan 2025

Overall, volume growth is likely to be in the range of 3-8 per cent for two-wheelers and 5-7 per cent for passenger vehicles owing to healthy demand from urban and rural areas and pending order books.

US WHO Exit Won't Impact India: Experts

US WHO Exit Won't Impact India: Experts

Rediff.com   22 Jan 2025

'Both international cooperation and self-reliance will now acquire new purpose.'

Gautam Singhania-backed SCCG seeks licence to restore foreign cars

Gautam Singhania-backed SCCG seeks licence to restore foreign cars

Rediff.com   13 Jan 2025

Car restoration service provider Super Car Club Garage (SCCG), backed by Raymond chairman and managing director Gautam Singhania, has sought the Centre's green light for a licence to import foreign vehicles for restoration and subsequent re-export.

20 EV Launches In 2025

20 EV Launches In 2025

Rediff.com   2 Jan 2025

Maruti Suzuki, Tata Motors, Mahindra & Mahindra, Hyundai and MG Motors are gearing up to introduce EVs in India.

Fake medicines worth Rs 6.6 crore seized in Kolkata

Fake medicines worth Rs 6.6 crore seized in Kolkata

Rediff.com   1 Jan 2025

'Anti-cancer, anti-diabetic, and other drugs suspected to be spurious were seized from the raid carried out at the firm.'

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com   30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Offers Pour In At IITs' Placement Season

Offers Pour In At IITs' Placement Season

Rediff.com   24 Dec 2024

Major recruiters, with double-digit offers at IIT campuses this year so far, include American Express, Barclays, BCG, Cars24, Deutsche Bank, Goldman Sachs, Google, Intel India, Meesho, Micron Technology, Microsoft, OLA, Oracle, Reliance, and Qualcomm.

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Rediff.com   23 Dec 2024

India's healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According to data, key contributors to the record fundraising included Sai Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), and Sagility India (Rs 2,107 crore).

E2W firms get serious about customer care support

E2W firms get serious about customer care support

Rediff.com   10 Dec 2024

Players like Ola Electric, Ather Energy, Kinetic Green and BGauss are introducing premium services and infrastructure enhancements.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com   9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.